RxSight, Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
RxSight, Inc. (RXST) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $6.54 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-02-25
- RxSight, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $6.54M, a 65.76% decline from fiscal 2024.
- RxSight, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $19.10M, a 49.31% increase from fiscal 2023.
- RxSight, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $12.79M, a 14.19% decline from fiscal 2022.
- RxSight, Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $14.91M, a 13.02% increase from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $6.54M 10-K · filed 2026-02-25 |
| 2024-12-31 | $19.10M 10-K · filed 2026-02-25 |
| 2023-12-31 | $12.79M 10-K · filed 2026-02-25 |
| 2022-12-31 | $14.91M 10-K · filed 2025-02-25 |
| 2021-12-31 | $13.19M 10-K · filed 2023-03-06 |
| 2020-12-31 | $9.82M 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |